Morning Overview on MSN
World’s 1st targeted sepsis treatment hailed as potential lifesaving breakthrough
Grand Pharmaceutical Group Limited announced that its experimental drug STC3141 met the primary clinical endpoint in a Phase ...
Adding an SGLT2 inhibitor to standard care did not improve clinical outcomes in critically ill patients with acute organ dysfunction, an open-label randomized trial involving intensive care units ...
Sexual dysfunction was identified among nearly one-half of adults with systemic vasculitis in a cross-sectional study published in the Journal of Clinical Rheumatology, with older age and female sex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results